ZOTA Zota Health Care Q4 FY25 results (Jan–Mar 2025) and concall
Zota Health Care reported strong financial performance in Q4 FY25, with consolidated revenue growing 62% YoY and gross profit up 86% YoY, primarily driven by the Davaindia retail pharmacy chain. The company aggressively expanded its Davaindia network, adding 599 new COCO stores and increasing GMV significantly. While gross margins saw a temporary dip due to store closures, management expects steady improvement, though EBITDA may remain flat in FY26 due to continued aggressive expansion.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 59 | 68 | 78 |
| EBITDA | 3 | 1 | 4 |
| Net profit | 2 | 2 | 3 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
